We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+13.8%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$14.5B
AUM Growth
+$1.96B
Cap. Flow
+$582M
Cap. Flow %
4.02%
Top 10 Hldgs %
31.8%
Holding
146
New
31
Increased
52
Reduced
23
Closed
24

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$319M
2
IMMU
Immunomedics Inc
IMMU
+$296M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$216M
4
NYT icon
New York Times
NYT
+$130M
5
HLT icon
Hilton Worldwide
HLT
+$129M

Top Sells

Rank Stock Value
1
PPLI
People Inc
PPLI
+$456M
2
WUBA
58.com Inc
WUBA
+$268M
3
CRM icon
Salesforce
CRM
+$181M
4
QGEN icon
Qiagen
QGEN
+$123M
5
CZR
Caesars Entertainment Corporation
CZR
+$97.2M

Sector Composition

Rank Sector Weight
1 Healthcare 44.6%
2 Communication Services 17.58%
3 Technology 8.94%
4 Financials 7.39%
5 Industrials 5.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IQV icon
1
IQVIA
IQV
$42.8B
$556M 3.85%
3,526,636
-269,394
-7% -$42.2M
GOOG icon
2
Alphabet (Google) Class C
GOOG
$4.18T
$533M 3.69%
7,252,580
+2,831,580
+64% +$216M
IMMU
3
DELISTED
Immunomedics Inc
IMMU
$498M 3.45%
+5,860,000
New +$296M
TMO icon
4
Thermo Fisher Scientific
TMO
$233B
$484M 3.35%
1,095,578
+26,073
+2% +$10.8M
FIS icon
5
Fidelity National Information Services
FIS
$21.3B
$466M 3.22%
3,162,858
-427,270
-12% -$61.8M
CHTR icon
6
Charter Communications
CHTR
$17.9B
$458M 3.17%
733,191
-21,824
-3% -$12.9M
TMUS icon
7
T-Mobile US
TMUS
$196B
$416M 2.88%
3,636,981
+179,350
+5% +$19.9M
CNC icon
8
Centene
CNC
$32.1B
$411M 2.84%
7,050,000
+50,000
+0.7% +$3.11M
META icon
9
Meta Platforms (Facebook)
META
$1.4T
$404M 2.79%
1,542,045
+183,551
+14% +$47.3M
ABBV icon
10
AbbVie
ABBV
$468B
$372M 2.57%
4,250,000
+100,000
+2% +$9.41M
AON icon
11
Aon
AON
$75.3B
$362M 2.51%
1,756,344
+35,846
+2% +$7.16M
V icon
12
Visa
V
$693B
$343M 2.37%
1,716,704
-82,669
-5% -$16.5M
ELV icon
13
Elevance Health
ELV
$86.9B
$342M 2.37%
1,275,000
+25,000
+2% +$6.73M
WAB icon
14
Wabtec
WAB
$50.3B
$337M 2.33%
5,439,551
+1,114,190
+26% +$71.5M
MSFT icon
15
Microsoft
MSFT
$3.59T
$324M 2.24%
1,540,978
+12,779
+0.8% +$2.68M
EMB icon
16
PUT
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.7B
$320M 2.22%
+288,900
New +$32.4M
BSX icon
17
Boston Scientific
BSX
$73B
$316M 2.19%
+8,275,919
New +$319M
NYT icon
18
New York Times
NYT
$10.6B
$304M 2.1%
7,106,042
+2,968,500
+72% +$130M
INFO
19
DELISTED
IHS Markit Ltd. Common Shares
INFO
$299M 2.07%
3,812,944
-97,080
-2% -$7.73M
XLRN
20
DELISTED
Acceleron Pharma
XLRN
$293M 2.02%
2,600,000
+500,000
+24% +$49.8M
SHW icon
21
Sherwin-Williams
SHW
$84.1B
$283M 1.96%
1,217,358
-126,603
-9% -$27.6M
TIF
22
DELISTED
Tiffany & Co.
TIF
$265M 1.83%
2,287,000
+759,302
+50% +$92.2M
EXEL icon
23
Exelixis
EXEL
$13.4B
$263M 1.82%
10,750,000
+500,000
+5% +$11.7M
BMY icon
24
Bristol-Myers Squibb
BMY
$137B
$226M 1.56%
3,750,000
+125,000
+3% +$7.52M
PANW icon
25
Palo Alto Networks
PANW
$292B
$217M 1.5%
5,327,352
+214,722
+4% +$8.93M
1
2 3 4 5

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q3 2020 Portfolio in Review

As of Q3 2020, Thomas Steyer held 146 positions worth $14.5B, up 16% from $12.5B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Thomas Steyer deployed $582M of net new capital in Q3 2020, opening 31 new positions and adding to 52 existing holdings. Its largest new stake was Boston Scientific: 8,275,919 shares worth $316M.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 43% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Salesforce, an estimated $181M trimmed.

  • Thomas Steyer's largest Q3 2020 buy was Boston Scientific: 8,275,919 shares worth $316M.
  • Thomas Steyer added most to Alphabet (Google) Class C in Q3 2020, an estimated $216M increase.
  • Thomas Steyer's biggest Q3 2020 reduction was Salesforce, cutting an estimated $181M.
  • Thomas Steyer fully exited People Inc in Q3 2020, selling an estimated $456M.
  • Thomas Steyer's ten largest holdings make up 32% of its $14.5B portfolio in Q3 2020.
  • Thomas Steyer opened 31 new positions and closed 24 in Q3 2020.
  • Thomas Steyer's portfolio value rose 16% quarter-over-quarter to $14.5B.

Based on Farallon Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.